IPO

new york stock exchange
Biotech

Inflammation biotech Evommune heads to NYSE with $150M IPO

The company will use the proceeds to fund a pair of clinical-stage candidates.
James Waldron Nov 6, 2025 7:00am
IPO art

Evommune prices IPO amid government shutdown

Oct 30, 2025 12:34pm
IPO initial public offering

MapLight goes public via $250M IPO to fund Cobenfy competitor

Oct 27, 2025 6:45am
piggy bank surrounded by question marks

PE dealmaking, exit counts on the rise in Q3: PitchBook

Oct 20, 2025 5:05pm
IPO initial public offering markets raise financing

Inflammation biotech Evommune eyes IPO to fund dermatitis trials

Oct 10, 2025 6:35am
3D Rendering futuristic robot technology development artificial intelligence

MapLight illuminates $262M IPO plans to fund Cobenfy competitor

Oct 7, 2025 6:30am